Concurrent B-cell acute lymphoblastic leukemia and plasma cell neoplasm with plasmablastic features supporting divergent evolution from a shared precursor: a case report - Scorecard - MDSpire
Advertisement
Concurrent B-cell acute lymphoblastic leukemia and plasma cell neoplasm with plasmablastic features supporting divergent evolution from a shared precursor: a case report
Clinical Scorecard: Simultaneous Presence of B-cell Acute Lymphoblastic Leukemia and Plasma Cell Neoplasm with Plasmablastic Characteristics Suggesting Divergent Evolution from a Common Precursor: A Case Study
At a Glance
Category
Detail
Condition
B-cell Acute Lymphoblastic Leukemia and Plasma Cell Neoplasm
Key Mechanisms
Clonal divergence from a common precursor cell
Target Population
76-year-old man with cytopenias and leukocytosis
Care Setting
Hematology clinic
Key Highlights
Rare co-occurrence of B-ALL and plasma cell neoplasm reported.
Initial diagnosis established through bone marrow evaluation and immunophenotyping.
Treatment directed initially at B-ALL, leading to remission of both malignancies.
Subsequent disease evolution showed expansion of plasmablastic/plasma cell population.
Genomic analysis indicated two clonally related but distinct malignancies.
Guideline-Based Recommendations
Diagnosis
Bone marrow aspirate cytology and flow cytometry for immunophenotyping.
Management
Initial treatment with acute lymphoblastic leukemia protocol including vincristine and methylprednisolone.
Monitoring & Follow-up
Follow-up bone marrow evaluations to assess disease evolution and response to therapy.
Risks
Potential toxicity from redirected treatment toward myeloma-based regimen.
Patient & Prescribing Data
76-year-old male with B-ALL and concurrent plasma cell neoplasm.
Initial therapy induced remission but later required a shift in treatment approach due to disease evolution.
Clinical Best Practices
Integrated genomic and immunophenotypic analysis to understand disease biology.
Monitoring for clonal evolution in B-cell malignancies.
